SEC Form 4 · accession 0001209191-15-063456
Paratek Pharmaceuticals, Inc. · PRTK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy R Franson
Director
Period of report
Jul 31, 2015
Accepted (ET)
Aug 4, 2015 · 12:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178711
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1,F2 | $25.16 | Jul 31, 2015 | A | 20,000 | A | — | Jul 30, 2025 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1The exercise price is equal to the closing sales price per share of Common Stock as reported on The Nasdaq Global Market on the date of grant.
- F2The shares shall vest in 36 equal monthly installments measured commencing from July 21, 2015.